• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English

Welcome to the international HTA database


Showing [16495 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2013     Penn Medicine Center for Evidence-based Practice (CEP) Nutrition during hospitalization for pediatric bronchiolitis
2013     Blue Cross Blue Shield Association (BCBS) Special Report: multiple molecular testing of cancers to identify targeted therapies
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Routine blood tests for patients in the intensive care unit: clinical effectiveness, cost-effectiveness, and guidelines
2013     HAYES, Inc. Dry needling for myofascial pain in adults
2013     Penn Medicine Center for Evidence-based Practice (CEP) Dexmedetomidine for sedation of cardiac surgical patients
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Swabbing techniques for the detection of bacterial colonization in wounds: comparative clinical evidence and guidelines
2013     Belgian Health Care Knowledge Centre (KCE) Supportive treatment for cancer – Part 3: Treatment of pain: most common practices
2013     Penn Medicine Center for Evidence-based Practice (CEP) Nebulized hypertonic saline treatment for infants with bronchiolitis
2013     Blue Cross Blue Shield Association (BCBS) Breast-Specific Gamma Imaging (BSGI), Molecular Breast Imaging (MBI), or scintimammography with breast-specific gamma camera
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Long term Use of Clopidogrel for Patients with Stents or Acute Coronary Syndrome: A Review of Clinical and Cost-effectiveness and Guidelines
2013     HAYES, Inc. Endovascular repair of isolated iliac artery aneurysms
2013     Penn Medicine Center for Evidence-based Practice (CEP) Appropriate use of lumbar fusion surgery
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Management of diabetes in the long-term care population: a review of guidelines
2013     Belgian Health Care Knowledge Centre (KCE) The decisional process for the choice of active surveillance in localized prostate cancer
2013     Penn Medicine Center for Evidence-based Practice (CEP) Oxygen saturation discharge thresholds for infants admitted with bronchiolitis
2013     Blue Cross Blue Shield Association (BCBS) Special Report: exome sequencing for clinical diagnosis of patients with suspected genetic disorders
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Long term use of clopidogrel for patients with stents or acute coronary syndrome: a review of clinical and cost-effectiveness and guidelines
2013     HAYES, Inc. Extracorporeal shock wave therapy for chronic plantar fasciitis
2013     Penn Medicine Center for Evidence-based Practice (CEP) Management of back pain following cardiac electrophysiology procedures
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Vaginal preparation prior to cesarean delivery: clinical evidence
2013     Belgian Health Care Knowledge Centre (KCE) Organisation of aftercare for patients with severe burn injuries
2013     Penn Medicine Center for Evidence-based Practice (CEP) Scales for assessing inpatients' risk of accidental falls
2013     Blue Cross Blue Shield Association (BCBS) Handheld radiofrequency spectroscopy for intraoperative margin assessment during breast-conserving surgery
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Photo-activated disinfection therapy for non-dental surgery: review of the clinical effectiveness
2013     HAYES, Inc. Fecal calprotectin assay for management of crohn's disease
2013     Penn Medicine Center for Evidence-based Practice (CEP) Use of midodrine with vasopressors in the intensive care unit
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Azilsartan Medoxomil + Chlorthalidone (Edarbyclor- Takeda Canada Inc.) indication: severe hypertension
2013     Penn Medicine Center for Evidence-based Practice (CEP) Frequently-overused technologies
2013     Blue Cross Blue Shield Association (BCBS) Ocriplasmin for symptomatic vitreomacular adhesion
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Hemolysis and blood infusion pumps for patients receiving blood or blood components: standards and evidence-based guidelines: standards and evidence-based guidelines
2013     HAYES, Inc. Gastric electrical stimulation for gastroparesis
2013     Penn Medicine Center for Evidence-based Practice (CEP) Physician training and credentialing for robotic surgery in obstetrics and gynecology
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Technologies assisting in remote consultations for the diagnosis of stroke: a review of the clinical evidence
2013     Penn Medicine Center for Evidence-based Practice (CEP) Routine replacement of peripheral intravenous catheters
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) C1-esterase inhibitor (Berinert®)
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Bariatric surgery for obese patients with co-morbidities: a review of clinical effectiveness, cost-effectiveness, and guidelines
2013     HAYES, Inc. Laser therapy for psoriasis
2013     Penn Medicine Center for Evidence-based Practice (CEP) Obstetric early warning systems 
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Appropriateness of CT imaging to support the diagnosis of stroke: a review of the clinical evidence
2013     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Study of adherence to Recombinant Growth Hormone treatment of children with a GH deficiency: contributions to treatment control and economic impact
2013     NIHR Health Technology Assessment programme Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of multicentre randomised trial (the REFLUX trial)
2013     Penn Medicine Center for Evidence-based Practice (CEP) Controlled medication agreements for opioid use in chronic pain
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Linagliptin/metformin (Jentadueto®)
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) O-Arm technology in spinal, neurological, orthopedic, or trauma surgery settings: clinical effectiveness and benefits and harms to patients and hospital staff
2013     HAYES, Inc. Maggot therapy for nonhealing wounds
2013     Penn Medicine Center for Evidence-based Practice (CEP) Systematic reviews of robotic surgery in obstetrics and gynecology
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Linagliptin-metformin (Jentadueto - Boehringer Ingelheim (Canada) Ltd.) indication: type 2 diabetes mellitus
2013     Penn Medicine Center for Evidence-based Practice (CEP) Cognitive and procedural skills of aging physicians
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Perampanel (Fycompa®)
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Intraoperative monitoring during spinal or neurological surgeries: clinical effectiveness and guidelines
2013     HAYES, Inc. Percutaneous pulmonary valve implantation for right ventricular outflow tract defects
2013     Penn Medicine Center for Evidence-based Practice (CEP) Specialized geriatric care for hospitalized inpatients
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Perampanel (Fycompa - Eisai Ltd.) indication: epilepsy, partial-onset seizures
2013     Penn Medicine Center for Evidence-based Practice (CEP) Synthetic fleece (Polartec) attire: update
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Aclidinium bromide (Eklira® Genuair®)
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Indigenous knowledge for mental illness and chronic disease: clinical effectiveness and guidelines
2013     HAYES, Inc. Photodynamic therapy for head and neck cancer
2013     Penn Medicine Center for Evidence-based Practice (CEP) Management of patients after the removal of an indwelling urinary catheter
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Azilsartan Medoxomil (Edarbi - Takeda Canada Inc.) indication: mild to moderate essential hypertension
2013     NIHR Health Technology Assessment programme Cancer of Oesophagus or Gastricus - New Assessment of Technology of Endosonography (COGNATE): report of pragmatic randomised trial
2013     Agency for Healthcare Research and Quality (AHRQ) Epoetin and darbepoetin for managing anemia in patients undergoing cancer treatment: comparative effectiveness update
2013     Penn Medicine Center for Evidence-based Practice (CEP) Community health workers
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Adalimumab (Humira®)
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Management of coronary artery disease in primary and community care: guidelines
2013     HAYES, Inc. Photoscreening for the detection of amblyopia risk factors in children
2013     Penn Medicine Center for Evidence-based Practice (CEP) Nurse-directed protocols for removal of indwelling urinary catheters
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Distance consultation for chronic, non-healing, lower extremity wounds: clinical evidence
2013     NIHR Health Technology Assessment programme AESOPS: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of opportunistic screening and stepped care interventions for older hazardous alcohol users in primary care
2013     Agency for Healthcare Research and Quality (AHRQ) Childhood obesity prevention programs: comparative effectiveness review and meta-analysis
2013     Penn Medicine Center for Evidence-based Practice (CEP) Intravenous or rectal acetaminophen for post-operative pain
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ceftaroline fosamil (Zinforo®)
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Heating standards for magnetic resonance conditional medical devices: clinical evidence
2013     HAYES, Inc. Platelet function assays for patients on antiplatelet therapy undergoing cardiac surgery
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Plasma vaporization for the treatment of benign prostatic hypertrophy: clinical and cost-effectiveness, and safety
2013     Penn Medicine Center for Evidence-based Practice (CEP) Disinfecting caps and antimicrobial locks for reducing blood stream infections associated with central venous catheters
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ingenol mebutate (Picato®)
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools compared to parental concern for identifying speech and language delays in preschool children: a review of the diagnostic accuracy
2013     HAYES, Inc. Prophylactic oophorectomy for the prevention of ovarian cancer
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of surgical masks in the operating room: a review of the clinical effectiveness and guidelines
2013     Penn Medicine Center for Evidence-based Practice (CEP) Relationship between hemoglobin A1c levels and complications after elective hip and knee surgery
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Darunavir (Prezista®)
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) GreenLight laser for the treatment of benign prostatic hypertrophy: clinical and cost-effectiveness, and safety
2013     HAYES, Inc. Pyrocarbon proximal interphalangeal and metacarpophalangeal joint implants
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Cleansing of the cervix prior to hysterosalpingogram: clinical evidence and guidelines
2013     NIHR Health Technology Assessment programme Dabigatran for the prevention of stroke and systemic embolism in atrial fibrillation: A NICE single technology appraisal
2013     Penn Medicine Center for Evidence-based Practice (CEP) Esophageal temperature measurement to prevent complications of catheter ablation
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ferumoxytol (Rienso®)
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Community-based programs to improve early childhood health outcomes: guidelines and recommendations
2013     HAYES, Inc. Risk-reducing (prophylactic) mastectomy
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) CPAP treatment for adults with obstructive sleep apnea: review of the clinical and cost-effectiveness and guidelines
2013     NIHR Health Technology Assessment programme The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients
2013     Penn Medicine Center for Evidence-based Practice (CEP) Hourly rounding and other interventions to improve patient satisfaction associated with responsiveness
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Lapatinib (Tyverb®)
2013     NIHR Health Technology Assessment programme Does short cycle antiretroviral therapy impact on inflammation, immune activation, thrombogenesis and CD4 cell dynamics?
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Non-steroidal anti-inflammatory drugs for pain: comparative clinical and cost-effectiveness
2013     HAYES, Inc. Transanal hemorrhoidal dearterialization
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Dressing materials for the treatment of pressure ulcers in patients in long-term care facilities: a review of the comparative clinical effectiveness and guidelines
2013     Malaysian Health Technology Assessment (MaHTAS) X Collar versus conventional cervical collar
2013     Penn Medicine Center for Evidence-based Practice (CEP) Securement devices for peripherally inserted central venous catheters (PICCs) and Midline catheters
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ulipristal acetate (Esmya®)